Double-Blind, Randomized, Placebo-Controlled Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich’s Ataxia

Theresa A. Zesiewicz, Kelly L. Sullivan, J. Farmer, C. Kamp, R. Chen, A. Brocht, S. Bennett, Israt Jahan, Clifton L. Gooch, Amber M. Miller, David R. Lynch

Research output: Contribution to book or proceedingChapter

Abstract

This conference abstract was published in the Proceedings of the American Academy of Neurology Annual Meeting.
Original languageAmerican English
Title of host publicationProceedings of the American Academy of Neurology Annual Meeting
StatePublished - Apr 13 2011

Keywords

  • Chantix®
  • Double-blind
  • Friedreich's Ataxia
  • Pilot study
  • Placebo-controlled
  • Randomized
  • Treatment
  • Varenicline

DC Disciplines

  • Epidemiology
  • Public Health

Fingerprint

Dive into the research topics of 'Double-Blind, Randomized, Placebo-Controlled Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich’s Ataxia'. Together they form a unique fingerprint.

Cite this